GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
5,286
Funds Holding Change
-16
Funds Holding Growth
-0.3%
Value
$1.18T
Holding in Top 10
564
Top 10 Change
-14
Top 10 Growth
-2%
Value Growth
-0.7%
New
222
Increased
2,465
Reduced
2,217
Closed
161
Capital Inflow
$38.6B
Capital Outflow
$62B
Net Capital Flow
-$23.5B
Capital Flow Change
+$19.6B
Calls
$26.8B
Puts
$28.6B
Net Calls
-$1.8B
Put/Call Ratio
1.07